Objective: To isolate and evaluate bioactive compounds from Curcuma caesia rhizomes for its novel potential anti-tuberculosis agents. Methods: Curcuma caesia rhizomes were meticulously collected and authenticated. Phytochemical screening and GC-MS analyses were conducted to identify the chemical constituents of the plant. Isolation of a bioactive phytoconstituent was achieved, followed by the characterization using HPLC, TLC, and FTIR techniques. The isolated compound was then subjected to biological evaluation, including anti-tuberculosis activity assessment and MTT assay, revealing its potential as a novel anti-tuberculosis agent. Findings: Alkaloids, flavonoids, phytosterols, saponins, and phenolics were identified among the chemical components in the early phytochemical screening. Bioactive compounds were extracted using methanol, and the compound, (+)-3-Bromocamphor-8-Sulfonic Acid Ammonium Salts, showed positive for anti-tuberculosis agent. In silico docking studies of isolated compounds and proteins showed conventional hydrogen bonds with 8hcr 5sxf. The compound adheres to Lipinski's rule of five, suggesting its potential as a drug-like molecule. Novelty: The isolation of novel (+)-3-Bromocamphor-8-sulfonic acid ammonium salts showed a potential antituberculosis role that can act against drug-resistant strains of Mycobacterium tuberculosis. Adherence to Lipinski's rule of five suggests that it is a drug-like molecule, emphasizing its potential for further drug development.